Introduction: Coronavirus disease 2019 (COVID-19) predominantly affects the pulmonary tract, causing mainly respiratory symptoms with some involvement of other organ systems. Liver injury has frequently been reported in COVID-19 patients. The clinical relevance of liver injury related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection remains unclear, with a need for studies on the impact of liver function tests (LFTs) abnormalities at baseline. Methods: This cross-sectional study aimed to detect an association of LFTs with COVID-19 among Sudanese patients in Khartoum State, the Republic of Sudan's national capital city, from August to December 2021. A total of 90 patients with COVID-19 confirmed by real-time polymerase chain reaction (RT-PCR) were enrolled; their ages ranged from 20 to 80. 5 ml of venous blood samples were collected from each participant by standard venipuncture and placed into a heparin container for chemical analysis. The Mindray device was used to analyze the plasma, and the results were shown on a sizable color liquid crystal display (LCD). Results: The results showed that there was a significant difference (p. value ≤ 0.05) between levels of liver function tests according to the different categories of COVID-19 cases (mild, moderate, and severe). Also, the results indicated that there was an insignificant difference (p. value ˃ 0.05) between levels of liver function tests according to gender. Moreover, the results found that there was no correlation between liver function parameters and age. Conclusions: The present study concluded that the levels of liver function tests were affected by the severity of COVID-19 infection.
Published in | Biomedical Sciences (Volume 9, Issue 3) |
DOI | 10.11648/j.bs.20230903.12 |
Page(s) | 60-63 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
COVID-19, LFTs, Acute Respiratory Distress Syndrome
[1] | Li Q. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020. |
[2] | World Health Organization. https://covid 19.who.int/. Accessed June 17, 2020. |
[3] | Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch AcadEmerg Med. 2020; 8 (1): e17. |
[4] | Pan D. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. E Clinical Medicine. 2020; 23: 100404. |
[5] | Smilowitz. C-reactive protein and clinical outcomes in patients with COVID-19. European heart journal. 2021; 42 (23); 2270-2279. |
[6] | Mantovani A. Coronavirus disease 2019 and prevalence of chronic liver disease: a meta-analysis. Liver Int. 2020; 40 (6): 1316–1320. |
[7] | American Liver Foundation, 2020. https://liverfoundation.org |
[8] | Zheng BJ. SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis. 2021; 10 (2): 176. |
[9] | Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-19 infection. Clin Chem Lab Med 2020; 58: 1131–4. |
[10] | Jayasri K, Pooja CH, Padmaja K, Prasad PE. Review on biochemical alterations in COVID-19 patients. Int J Clin Biochem Res 2020; 7 (3): 307-311. |
[11] | Wei Xu. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. 2021; 102- 122, 140-147. |
[12] | Weber S, Hellmuth JC, Scherer. Liver function test abnormalities at hospital admission are associated with severe course of SARS-Cov-2 infection: a prospective cohort study. Gut 2021; 70: 1925-1932. |
[13] | Menon T, Sharma R, Earthineni G, Lftikhar H, Sondhi M, Shams S, Khurshid A, Khan H, Rathore S, Singh R. Association of Gastrointestinal System With Severity and Mortality of COVID-19: A systemic Review and Meta-Analysis. Cureus. 2021; 13 (12): e13317. |
[14] | Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. |
[15] | Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020; 58 (7): 1021–8. |
APA Style
Mogtaba Ahmed Mohammed, Alaa Abdalla Ibrahim, Ranya Adel Hamad, Jasim Mohamed Adam, Misson Shamsalfalah Ahmed, et al. (2023). Impact of COVID-19 on Liver Function Tests Among Sudanese Patients: A Cross-Sectional Study of Khartoum State. Biomedical Sciences, 9(3), 60-63. https://doi.org/10.11648/j.bs.20230903.12
ACS Style
Mogtaba Ahmed Mohammed; Alaa Abdalla Ibrahim; Ranya Adel Hamad; Jasim Mohamed Adam; Misson Shamsalfalah Ahmed, et al. Impact of COVID-19 on Liver Function Tests Among Sudanese Patients: A Cross-Sectional Study of Khartoum State. Biomed. Sci. 2023, 9(3), 60-63. doi: 10.11648/j.bs.20230903.12
AMA Style
Mogtaba Ahmed Mohammed, Alaa Abdalla Ibrahim, Ranya Adel Hamad, Jasim Mohamed Adam, Misson Shamsalfalah Ahmed, et al. Impact of COVID-19 on Liver Function Tests Among Sudanese Patients: A Cross-Sectional Study of Khartoum State. Biomed Sci. 2023;9(3):60-63. doi: 10.11648/j.bs.20230903.12
@article{10.11648/j.bs.20230903.12, author = {Mogtaba Ahmed Mohammed and Alaa Abdalla Ibrahim and Ranya Adel Hamad and Jasim Mohamed Adam and Misson Shamsalfalah Ahmed and Musab Alsiddig Altayb and Mohammed Alhendi Ali and Amasi Abbas Idrees and Alaaeldeen Balal Ahmed}, title = {Impact of COVID-19 on Liver Function Tests Among Sudanese Patients: A Cross-Sectional Study of Khartoum State}, journal = {Biomedical Sciences}, volume = {9}, number = {3}, pages = {60-63}, doi = {10.11648/j.bs.20230903.12}, url = {https://doi.org/10.11648/j.bs.20230903.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bs.20230903.12}, abstract = {Introduction: Coronavirus disease 2019 (COVID-19) predominantly affects the pulmonary tract, causing mainly respiratory symptoms with some involvement of other organ systems. Liver injury has frequently been reported in COVID-19 patients. The clinical relevance of liver injury related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection remains unclear, with a need for studies on the impact of liver function tests (LFTs) abnormalities at baseline. Methods: This cross-sectional study aimed to detect an association of LFTs with COVID-19 among Sudanese patients in Khartoum State, the Republic of Sudan's national capital city, from August to December 2021. A total of 90 patients with COVID-19 confirmed by real-time polymerase chain reaction (RT-PCR) were enrolled; their ages ranged from 20 to 80. 5 ml of venous blood samples were collected from each participant by standard venipuncture and placed into a heparin container for chemical analysis. The Mindray device was used to analyze the plasma, and the results were shown on a sizable color liquid crystal display (LCD). Results: The results showed that there was a significant difference (p. value ≤ 0.05) between levels of liver function tests according to the different categories of COVID-19 cases (mild, moderate, and severe). Also, the results indicated that there was an insignificant difference (p. value ˃ 0.05) between levels of liver function tests according to gender. Moreover, the results found that there was no correlation between liver function parameters and age. Conclusions: The present study concluded that the levels of liver function tests were affected by the severity of COVID-19 infection.}, year = {2023} }
TY - JOUR T1 - Impact of COVID-19 on Liver Function Tests Among Sudanese Patients: A Cross-Sectional Study of Khartoum State AU - Mogtaba Ahmed Mohammed AU - Alaa Abdalla Ibrahim AU - Ranya Adel Hamad AU - Jasim Mohamed Adam AU - Misson Shamsalfalah Ahmed AU - Musab Alsiddig Altayb AU - Mohammed Alhendi Ali AU - Amasi Abbas Idrees AU - Alaaeldeen Balal Ahmed Y1 - 2023/08/28 PY - 2023 N1 - https://doi.org/10.11648/j.bs.20230903.12 DO - 10.11648/j.bs.20230903.12 T2 - Biomedical Sciences JF - Biomedical Sciences JO - Biomedical Sciences SP - 60 EP - 63 PB - Science Publishing Group SN - 2575-3932 UR - https://doi.org/10.11648/j.bs.20230903.12 AB - Introduction: Coronavirus disease 2019 (COVID-19) predominantly affects the pulmonary tract, causing mainly respiratory symptoms with some involvement of other organ systems. Liver injury has frequently been reported in COVID-19 patients. The clinical relevance of liver injury related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection remains unclear, with a need for studies on the impact of liver function tests (LFTs) abnormalities at baseline. Methods: This cross-sectional study aimed to detect an association of LFTs with COVID-19 among Sudanese patients in Khartoum State, the Republic of Sudan's national capital city, from August to December 2021. A total of 90 patients with COVID-19 confirmed by real-time polymerase chain reaction (RT-PCR) were enrolled; their ages ranged from 20 to 80. 5 ml of venous blood samples were collected from each participant by standard venipuncture and placed into a heparin container for chemical analysis. The Mindray device was used to analyze the plasma, and the results were shown on a sizable color liquid crystal display (LCD). Results: The results showed that there was a significant difference (p. value ≤ 0.05) between levels of liver function tests according to the different categories of COVID-19 cases (mild, moderate, and severe). Also, the results indicated that there was an insignificant difference (p. value ˃ 0.05) between levels of liver function tests according to gender. Moreover, the results found that there was no correlation between liver function parameters and age. Conclusions: The present study concluded that the levels of liver function tests were affected by the severity of COVID-19 infection. VL - 9 IS - 3 ER -